Compare POOL & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POOL | AMRX |
|---|---|---|
| Founded | 1993 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 6.4B |
| IPO Year | 1997 | 2018 |
| Metric | POOL | AMRX |
|---|---|---|
| Price | $160.67 | $20.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $217.00 | $22.71 |
| AVG Volume (30 Days) | 696.9K | ★ 2.1M |
| Earning Date | 10-22-2026 | 10-29-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | ★ 1.45 | 0.37 |
| Revenue | ★ $5,289,396,000.00 | N/A |
| Revenue This Year | $2.82 | $4.54 |
| Revenue Next Year | $3.49 | $9.14 |
| P/E Ratio | $112.62 | ★ $54.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $160.38 | $9.56 |
| 52 Week High | $313.71 | $21.18 |
| Indicator | POOL | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 28.71 | 64.58 |
| Support Level | $160.38 | $16.59 |
| Resistance Level | $190.00 | $21.18 |
| Average True Range (ATR) | 4.23 | 0.93 |
| MACD | -0.04 | 0.19 |
| Stochastic Oscillator | 3.76 | 79.20 |
Pool Corp is a wholesale distributor of swimming pool supplies, equipment, and related leisure products. The company's products include pool pumps, filters, heaters, and cleaners; pool maintenance products like chemicals, supplies, and repair parts; irrigation and landscape maintenance products; and outdoor lighting, grills, outdoor kitchen components, etc. These products are offered through branded distribution networks such as Horizon, SCP, Poolcorp Commercial Aquatics, Sun Wholesale Supply, Superior Pool Products, and NPT. The company's customers include pool builders, pool service companies, retail stores, commercial pool operators, and landscape contractors. Geographically, it generates maximum revenue from the United States, followed by other markets like Europe and Australia.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.